Calmodulin Mutations in Human Disease.

Area of Science:

• Cellular biology
• Molecular cardiology
• Biochemistry

Background:

• Calcium ions (Ca2+) are crucial for cellular signaling, with calmodulin (CaM) acting as a key mediator.
• CaM regulates diverse cellular processes, including neuronal gene expression and cardiac action potentials.
• CaM is encoded by highly conserved CALM1-3 genes, and mutations cause severe cardiac disorders.

Approach:

• Review of research on calmodulinopathic CaM mutations.
• Identification of CaM-modulated proteins implicated in disease pathogenesis.
• Evaluation of the molecular mechanisms underlying CaM-related cardiac dysfunction.

Key Points:

• Mutations in CALM1-3 genes lead to calmodulinopathies, such as long QT syndrome (LQTS) and catecholaminergic polymorphic ventricular tachycardia (CPVT).
• Key CaM targets involved in disease include the cardiac L-type Ca2+ channel (CaV1.2) and ryanodine receptor 2 (RyR2).
• Understanding CaM variant mechanisms is crucial for elucidating the pathogenesis of these inherited cardiac conditions.

Conclusions:

• CaM plays a vital role in cardiac function, and its dysfunction due to mutations has significant clinical implications.
• Research into CaM variants and their interactions with targets like CaV1.2 and RyR2 provides insights into calmodulinopathies.
• Further investigation into CaM's role in cellular signaling is essential for developing therapeutic strategies for related heart diseases.